This result is common in cost of illness studies in other areas of treatment, as incidence-based approaches have more stringent requirements regarding the information needed to carry out the analysis; indeed, incidence-based studies require life-expectancy and cost estimates incurred throughout the natural course of the disease.
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}